Home >> Top News >> FDA clears Panther Fusion Flu A/B/RSV assay

FDA clears Panther Fusion Flu A/B/RSV assay

Print Friendly, PDF & Email

Oct. 12, 2017Hologic has received 510(k) clearance from the FDA for its Panther Fusion Flu A/B/RSV assay for use on its Panther Fusion system.

The Panther Fusion is available as a full system or as a module that can be attached to existing Panther systems. The Panther Fusion is capable of running polymerase chain reaction assays in addition to tests based on transcription-mediated amplification.

“Hologic has long-standing expertise in flu extending back to the introduction of ProFlu+, the first FDA-cleared Flu A/B/RSV assay on the market in 2008,” Tom West, president of the Diagnostic Solutions Division, Hologic, said in a statement. “This expertise has translated to the development of a test with excellent performance, and that test is now available on our integrated platform, which fully automates all aspects of testing, from sample to result.”

More top news


Check Also

Aptima HBV Quant Assay gets PMA approval

Jan. 30, 2018—Hologic announced the FDA has granted PMA approval for the Aptima HBV Quant...